0000905718-17-000231.txt : 20170214
0000905718-17-000231.hdr.sgml : 20170214
20170214160305
ACCESSION NUMBER: 0000905718-17-000231
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20161231
FILED AS OF DATE: 20170214
DATE AS OF CHANGE: 20170214
EFFECTIVENESS DATE: 20170214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: TYNDALL CAPITAL PARTNERS L P
CENTRAL INDEX KEY: 0001219314
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-10427
FILM NUMBER: 17608515
BUSINESS ADDRESS:
STREET 1: 405 PARK AVENUE
STREET 2: SUITE 1104
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-446-2473
MAIL ADDRESS:
STREET 1: 405 PARK AVENUE
STREET 2: SUITE 1104
CITY: NEW YORK
STATE: NY
ZIP: 10022
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001219314
XXXXXXXX
12-31-2016
12-31-2016
false
TYNDALL CAPITAL PARTNERS L P
405 Park Avenue
Suite 1104
New York
NY
10022
13F HOLDINGS REPORT
028-10427
N
Jeffrey S. Halis
Manager
212-446-2460
/s/ Jeffrey S. Halis
New York
NY
02-14-2017
0
3
2854
true
INFORMATION TABLE
2
infotable.xml
ONCONOVA THERAPEUTICS INC
COM NEW
68232V306
1182
520832
SH
SOLE
520832
0
0
ONCONOVA THERAPEUTICS INC
*W EXP 07/07/202
68232V116
391
390624
SH
SOLE
390624
0
0
MMA CAP MGMT LLC
COM
55315D105
1281
67399
SH
SOLE
67399
0
0